Tenax Therapeutics
TENX
22 hedge funds and large institutions have $30.6M invested in Tenax Therapeutics in 2016 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 2 closing their positions.
30% more call options, than puts
Call options by funds: $112K | Put options by funds: $86K
20% more capital invested
Capital invested by funds: $25.4M → $30.6M (+$5.13M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4% less funds holding
Funds holding: 23 → 22 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
+$417K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$501K |
| 2 |
SC
Scotia Capital
Toronto,
Ontario, Canada
|
-$218K |
| 3 |
AC
Armistice Capital
New York
|
-$167K |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$83.4K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$83.4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AG
26
Advisor Group
Phoenix,
Arizona
| $3K | – | – | – |
|
|
BJ
27
BlackRock Japan
Tokyo,
Japan
| $3K | – | – | – |
|
|
TRCT
28
Tower Research Capital (TRC)
New York
| $3K | – | – | – |
|
|
IA
29
IFP Advisors
Tampa,
Florida
| $2K | – | – | – |
|
|
IWMPD
30
Integrated Wealth Management (Palm Desert)
Palm Desert,
California
| $1K | – | – | – |
|
31
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | – | – | – |
|
|
CA
32
Commerzbank Aktiengesellschaft
Frankfurt,
Germany
| $768 | – | – | – |
|
|
SC
33
Scotia Capital
Toronto,
Ontario, Canada
| – | -$218K | -3 | Closed |
|
34
Goldman Sachs
New York
| – | -$54K | -1 | Closed |
|
|
AIG
35
American International Group
New York
| – | -$3K | – | – |
|
36
Citadel Advisors
Miami,
Florida
| – | -$30K | – | – |
|
|
VKH
37
Virtu KCG Holdings
New York
| – | -$21K | – | – |
|
TENX Hedge Fund Activity: Q2 2016 in Review
22 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Tenax Therapeutics (TENX) for Q2 2016, worth a combined $30.6M — up 20% from $25.4M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of TENX and 1 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 0 added.
The largest buyer was EverPoint Asset Management, opening a new position worth an estimated $417K. The largest seller was Sabby Management, cutting an estimated $501K.
- 22 institutional investors held Tenax Therapeutics (TENX) as of Q2 2016, down from 23 in Q1 2016.
- Funds reported $30.6M of Tenax Therapeutics stock for Q2 2016, up 20% quarter-over-quarter.
- 1 fund opened new Tenax Therapeutics positions in Q2 2016 and 2 closed out, a net change of -1 holder.
- The largest Tenax Therapeutics buyer in Q2 2016 was EverPoint Asset Management, an estimated $417K added.
- The largest Tenax Therapeutics seller in Q2 2016 was Sabby Management, an estimated $501K sold.
Based on aggregated 13F filings for Q2 2016.